05.25.23 -- A Flexible, Cost-Efficient Way To Manage Clinical Trials Around The Globe

A CRO customer and a clinical sponsor both lacked an unblinded supply management role to oversee interactive response technologies (IRT) platform supply strategies and monitor clinical supply inventory levels. Examine how the IRT settings were optimized and the burden of managing the study’s complex global supply needs was removed.

Drug sponsors aiming to save time, reduce costs, and accelerate therapeutics to market are considering conducting studies that deviate from standard timelines. Learn how unconventional clinical trials impact the supply chain, the role a CDMO can play in facilitating these trials, and the possible risks of such studies.

While a well-planned direct-to-patient (DTP) model can help alleviate risks in patient enrollment (including diversity), retention, and adherence to overall study timelines and budgets, this model can prove to be more complex to get started than the traditional model. Explore how to ease trial troubles through DTP studies.